AbbVie shares sink after $21 bn deal for Pharmacyclics
AbbVie shares sank Thursday after the US pharmaceutical firm announced it will buy leukemia drug maker Pharmacyclics in a $21 billion deal.
Mar 5, 2015
0
3
AbbVie shares sank Thursday after the US pharmaceutical firm announced it will buy leukemia drug maker Pharmacyclics in a $21 billion deal.
Mar 5, 2015
0
3
Study results of CD19-directed chimeric antigen receptor (CAR) therapy using the Sleeping Beauty non-viral transduction system to modify T cells has demonstrated further promise in patients with advanced hematologic malignancies.
Dec 8, 2014
0
0
A new type of cancer therapy that targets an oncometabolite produced dramatic results in patients with advanced leukemia in an early-phase clinical trial. The study, led by Eytan M. Stein, MD, a medical oncologist at Memorial ...
Dec 7, 2014
0
1
Patients with a variety of hematological, or blood, cancers benefited from treatment with OTX015, a member of a new class of investigational epigenetic therapies that block the activity of bromodomain and extraterminal (BET)-bromodomain ...
Apr 8, 2014
0
0
A novel approach to cancer immunotherapy – strategies designed to induce the immune system to attack cancer cells – may provide a new and cost-effective weapon against some of the most deadly tumors, including ovarian ...
Mar 5, 2014
0
0
Adding bortezomib (Velcade) to standard preventive therapy for graft-versus-host-disease (GVHD) results in improved outcomes for patients receiving stem-cell transplants from mismatched and unrelated donors, according to ...
Dec 8, 2013
0
0
A team of scientists looking into the interplay of the immune system and cancer have found a link between a history of airborne allergies – in particular to plants, grass and trees – with risk of blood cancers in women.
Nov 23, 2013
0
0
A comprehensive genomic profiling test using next-generation sequencing has identified genomic alterations in more than half of pediatric cancer samples tested that would give clinicians potential targets on which to base ...
Nov 5, 2013
0
0
Auckland scientists have contributed to identifying a novel genetic pathway used in the stabilisation of blood vessels.
Sep 13, 2013
0
0
The benefits of hydroxyurea treatment in people with sickle cell disease are well known—fewer painful episodes, fewer blood transfusions and fewer hospitalizations. Now new research from the Johns Hopkins Children's Center ...
Sep 11, 2013
0
0